MRUS,Merus N.V. | Healthcare - www.financetom.com

Healthcare

MRUS

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Merus N.V.MRUS

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1.

The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma.

In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145.

The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Latest News >

North American Construction Group Closes Strategic Acquisition of Iron Mine Contracting, a Diversified Mining Services Contractor

Apr 7, 2026

ACHESON, Alberta, April 07, 2026 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. ( NOA ) (“NACG” or the “Company”) today announced the closing of its acquisition of Iron Mine Contracting (“IMC”), with a closing date of April 7, 2026 and an economic effective date of January 1, 2026 (the “Transaction”). Total expected consideration is approximately $125 million (the “Consideration”),...

Wealthspire’s Fiducient Advisors Acquires Axia Advisory

Apr 7, 2026

$1.9 billion retirement plan consultant in Indianapolis joins growing national platform NEW YORK--(BUSINESS WIRE)-- Wealthspire, an independent wealth management, institutional advisory, and business management firm, today announced that Fiducient Advisors has completed its acquisition of Axia Advisory, an Indianapolis-based retirement plan consulting and investment advisory firm with $1.9 billion in assets under management or advisement.* The addition of Axia...

Booz Allen Completes Acquisition of Defy Security

Apr 7, 2026

Accelerating Advanced Cybersecurity for New Age of Enterprise Threats MCLEAN, Va.--(BUSINESS WIRE)-- Booz Allen Hamilton ( BAH ) today announced it has completed its acquisition of Defy Security. The transaction was previously announced on February 17, 2026. Defy provides cybersecurity technology products and services to leading financial services, healthcare, manufacturing, and retail enterprises. Combining its robust customer base, sales infrastructure,...

Caturus' Wellhead-to-Water Strategy Achieves Major Milestones in Upstream and LNG Development

Apr 7, 2026

Commonwealth LNG Project achieves full commerciality Project financing process imminent for $12.5 billion LNG project Pre-FID site objectives progressing with EPC partner Technip Energies Pending $950 million acquisition of SM Energy assets remains on track HOUSTON, April 7, 2026 /PRNewswire/ -- Caturus announced today its Commonwealth LNG project has finalized customer offtake agreements to underpin financing of its LNG facility in...